GI and Neuro-endocrine Cancer
Contact Info
-
+123+456-7890 -
sarahlee@prohealth.com
Appointment Schedules
- Monday 09.00-12.00
- Wednesday 15.00-18.00
- Friday 09.00-12.00
Dr Philip Philip
MD, Ph.D, F.R.C.P
Professor of Oncology and Pharmacology, Wayne State University School of Medicine (WSU SOM), Leader of the Gastrointestinal and Neuroendocrine Multidisciplinary Team, Barbara Ann Karmanos Cancer Institute Detroit, Michigan USA
Degrees
-
University of California, San Francisco.
Medical degree
-
University of California, Los Angeles (UCLA) Medical Center.
Completed residency training in psychiatry
-
University of California, Berkeley.
Master of Public Health degree
Experiences
-
Worked in community mental health clinics, private practice, and academic medical centers.
-
Expertise in the treatment of mood disorders, anxiety disorders, and psychotic disorders.
-
Special interest in womens mental health and perinatal psychiatry.
-
Experience managing complex cases that involve both mental health and medical issues.
Awards/Achievements
-
Fellow of the American Psychiatric Association (FAPA).
-
Recognized for research contributions with grants from the National Institute of Mental Health (NIMH) and the American Foundation for Suicide Prevention.
Philip A. Philip, M.D., Ph.D., is an internationally renowned medical oncologist specializing in gastrointestinal cancers. He has led numerous breakthroughs in the areas of pancreatic and neuroendocrine tumors. His depth of expertise in research and treatment is matched by his passion for team and personalized patient care.
Dr Philip earned his medical degree at the University of Baghdad College of Medicine in Iraq. He earned his PhD in clinical pharmacology and pharmacogenetics at the University of London Guy’s Hospital Medical School in London, England. Dr Philip completed a residency at the University of Baghdad. He completed a fellowship in medical oncology at the University of Oxford in London, England, and at MD Anderson Cancer Center in Houston, Texas, United States. He is board certified in medical oncology in the United States and he is a fellow of the Royal College of Physicians in London. He joined Karmanos in 1995.
Dr. Philip's extensive influence in various national and international arenas includes chairing the GI committee for SWOG (the NCI-sponsored clinical trials collaborative), serving on the NCI's Cancer Therapy Evaluation Program committee, authoring more than 200 publications, co-editing a book on pancreatic cancer and serving as an international/national lecturer with more than 400 presentations. He is an awarded professor at Wayne State University.
